The MED deal will fall under a Pharma category deal (prescription based product)and therefore don’t read too much into the last deals. It’s a different ball game when it comes to Pharma deals." Yes, A I, very difficult to pick up stock FUM are …
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor …
Vancouver, British Columbia--(Newsfile Corp. - February 20, 2018) - CVR Medical Corp. (TSXV: CVM) (FSE: B3BN) (OTCQB: CRRVF) ('CVR Medical') announces the launch of pivotal clinical trials beginning Monday March 5, 2018 for …
The stock increased 1.94% or $6.62 during the last trading session ... and cut its stake in Syneron Medical Ltd. (NASDAQ:ELOS). Since August 15, 2017, it had 0 buys, and 2 sales for $9.28 million activity. On Thursday, February …
Medical supply stocks were the latest to get 'Amazon'ed' (AMZN) as reports that …
The stock has now more than doubled over the past 12 months, while the S&P 500 SPX, -0.17% has gained 15%.
"Our goal is to bring the best triple combination to patients as rapidly as possible, and this first Phase 3 study in combination with tezacaftor and ivacaftor is a …
Data from the phase III study will support regulatory submissions for elagolix and will be presented at an upcoming medical conference. Elagolix is under review in the …
The drop left shareholders' returns well below the market's since early 2015, but the stock remains in solidly positive territory over wider time frames, including the …